Benzinga

Benzinga

Benzinga

venerdì, settembre 04

Adaptive Biotechnologies Corp

ADPTNASDAQ
Trade with Public
Trade with Public
$24.28
-0.29-1.18%
In chiusura: Sep 4, 5:00 PM EST
$24.28
N/A
Post-mercato: 4:00 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Adaptive Biotechnologies Financials

Adaptive Biotechnologies (ADPT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
UPDATE: Adaptive Biotechnologies Q2 Adj. EPS $(0.10) Beats $(0.13) Estimate, Sales $71.553M Beat $65.886M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 41.18 percent increase over losses of $(0.17) per
Benzinga Newsdesk

PRO
Adaptive Biotechnologies Q2 EPS $(0.25) Misses $(0.14) Estimate, Sales $71.553M Beat $65.886M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.14) by 78.57 percent. This is a 47.06 percent decrease over losses of $(0.17) per
Benzinga Newsdesk

Stock Market Today: S&P 500, Nasdaq Futures Fall, Dow Gains Amid US-Iran Deal— SpaceX, Dave And Buster's, Western Digital In Focus (UPDATED)

(Editor’s note: The lede, headline, futures and economic data were updated.) U.S. stock futures were mixed on Tuesday, as the Dow Jones rose, while the Nasdaq 100 and S&P 500 declined, following Monday’s rally. The Labor Department reported that U.S. import prices advanced 1.9% in May, driven by surging fuel costs.
Rishabh Mishra

John Wiley & Sons, Dave and Buster's Entertainment And 3 Stocks To Watch Heading Into Tuesday

Stock futures lower, Wiley & Sons and Vince Holding expected to report earnings, Dave & Buster's and Adaptive Biotechnologies saw after-hours trading dips.
Avi Kapoor

PRO
Adaptive Biotechnologies Q1 EPS $(0.13) Beats $(0.17) Estimate, Sales $70.874M Beat $60.850M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.17) by 23.53 percent. This is a 35 percent increase over losses of $(0.20) per share
Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved